ProShare Advisors’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Sell |
|
|||||
|
2025
Q1 | $234K | Sell |
|
|||||
|
2024
Q4 | $436K | Buy |
|
|||||
|
2024
Q3 | $357K | Buy |
|
|||||
|
2024
Q2 | $209K | Sell |
|
|||||
|
2024
Q1 | $176K | Buy |
|
|||||
|
2023
Q4 | $113K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $148K | Sell |
|
|||||
|
2021
Q4 | $380K | Sell |
|
|||||
|
2021
Q3 | $405K | Sell |
|
|||||
|
2021
Q2 | $427K | Buy |
|
|||||
|
2021
Q1 | $368K | Buy |
|
|||||
|
2020
Q4 | $282K | Buy |
|